|
1
|
Torre LA, Siegel RL and Jemal A: Lung
cancer statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oser MG, Niederst MJ, Sequist LV and
Engelman JA: Transformation from non-small-cell lung cancer to
small-cell lung cancer: Molecular drivers and cells of origin.
Lancet Oncol. 16:e165–e172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group, : Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shepherd FA, Rodrigues Pereira J, Ciuleanu
T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S,
Smylie M, Martins R, et al: Erlotinib in previously treated
non-small-cell lung cancer. N Engl J Med. 353:123–132. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hellmann MD, Nathanson T, Rizvi H, Creelan
BC, Sanchez-Vega F, Ahuja A, Ni A, Novik JB, Mangarin LMB,
Abu-Akeel M, et al: Genomic features of response to combination
immunotherapy in patients with advanced non-small-cell lung cancer.
Cancer Cell. 33:843–852.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sequist LV, Bell DW, Lynch TJ and Haber
DA: Molecular predictors of response to epidermal growth factor
receptor antagonists in non-small-cell lung cancer. J Clin Oncol.
25:587–595. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davidson-Moncada J, Papavasiliou FN and
Tam W: MicroRNAs of the immune system: Roles in inflammation and
cancer. Ann N Y Acad Sci. 1183:183–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fabbri M: miRNAs as molecular biomarkers
of cancer. Expert Rev Mol Diagn. 10:435–444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Z, Zhao Z, Yang Y, Luo M, Zhang M,
Wang X, Liμ L, Hou N, Guo Q, Song T, et al: miR-99b-5p and
miR-203a-3p function as tumor suppressors by targeting IGF-1R in
gastric cancer. Sci Rep. 8:101192018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Massano J, Regateiro FS, Januario G and
Ferreira A: Oral squamous cell carcinoma: Review of prognostic
andet predictive factors. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 102:67–76. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mohler JL, Armstrong AJ, Bahnson RR,
D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano
CS, Horwitz EM, et al: Prostate cancer, version 1.2016. J Natl
Compr Canc Netw. 14:19–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu K, Liu X, Mao X, Xue L, Wang R, Chen L
and Chu X: MicroRNA-149 suppresses colorectal cancer cell migration
and invasion by directly targeting forkhead box transcription
factor FOXM1. Cell Physiol Biochem. 35:499–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumar B, Khaleghzadegan S, Mears B, Hatano
K, Kudrolli TA, Chowdhury WH, Yeater DB, Ewing CM, Luo J, Isaacs
WB, et al: Identification of miR-30b-3p and miR-30d-5p as direct
regulators of androgen receptor signaling in prostate cancer by
complementary functional microRNA library screening. Oncotarget.
7:72593–72607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Chen J and Li W: MicroRNA-149
targets specificity protein 1 to suppress human tongue squamous
cell carcinoma cell proliferation and motility. Oncol Lett.
13:851–856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jo SJ: Identification and functional
characterization of miR-30c-2-3p, miR-218-1-3p and miR-27a-5p as
tumor suppressors in lung adenocarcinoma. 2019.
|
|
21
|
Zhang C, Ge S, Hu C, Yang N and Zhang J:
MiRNA-218, a new regulator of HMGB1, suppresses cell migration and
invasion in non-small cell lung cancer. Acta Biochim Biophys Sin
(Shanghai). 45:1055–1061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ormond KE, Mortlock DP, Scholes DT,
Bombard Y, Brody LC, Faucett WA, Garrison NA, Hercher L, Isasi R,
Middleton A, et al: Human germline genome editing. Am J Hum Genet.
101:167–176. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Silver N, Best S, Jiang J and Thein SL:
Selection of housekeeping genes for gene expression studies in
human reticulocytes using real-time PCR. BMC Mol Biol. 7:332006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reck M, Rodriguez-Abreu D, Robinson AG,
Hui R, Csoszi T, Fulop A, Gottfried M, Peled N, Tafreshi A, Cuffe
S, et al: Pembrolizumab versus chemotherapy for PD-L1-positive
non-small-cell lung cancer. N Engl J Med. 375:1823–1833. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ke Y, Zhao W, Xiong J and Cao R: miR-149
inhibits non-small-cell lung cancer cells EMT by targeting FOXM1.
Biochem Res Int. 2013:5067312013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y
and Li D: Long non-coding RNA NEAT1 promotes non-small cell lung
cancer progression through regulation of miR-377-3p-E2F3 pathway.
Oncotarget. 7:51784–51814. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao L, Liμ L, Dong Z and Xiong J: miR-149
suppresses human non-small cell lung cancer growth and metastasis
by inhibiting the FOXM1/cyclin D1/MMP2 axis. Oncol Rep.
38:3522–3530. 2017.PubMed/NCBI
|
|
30
|
Chen P, Zhao Y and Li Y: miR-218 Inhibits
migration and invasion of lung cancer cell by regulating Robo1
expression. Zhongguo Fei Ai Za Zhi. 20:452–458. 2017.(In Chinese).
PubMed/NCBI
|
